13F Holdings
中文EN

DVA DAVITA INC.

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 927066 · Fiscal year ends 12/31

Financial factors as of 2025-06-30 (2025Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.1%
TTM net income YoY-2.7%
TTM EPS YoY8.0%
Revenue 3-yr CAGR4.2%
Net income 3-yr CAGR0.1%

Margins

Gross margin—
Operating margin15.8%
Net margin6.4%
FCF margin9.8%
EBITDA margin21.1%

Returns

ROE635.3%
ROA4.8%
ROIC (approx.)18.2%
Asset turnover0.76x

Leverage & solvency

Liabilities / assets91.1%
Debt / equity—
Current ratio1.39x
Interest coverage4.00x

Cash quality & payout

Operating cash flow / net income2.23x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue4.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$13.64B$12.82B$12.14B$11.61B$11.62B
SG&A expense$1.67B$1.54B$1.47B$1.36B$1.20B
Operating income$2.04B$2.09B$1.60B$1.34B$1.80B
Interest expense$539.92M$435.20M$373.95M$339.25M$267.05M
Pretax income$1.35B$1.53B$1.18B$966.28M$1.52B
Income tax$293.11M$279.66M$220.12M$198.09M$306.73M
Net income$746.80M$936.34M$691.53M$560.40M$978.45M
EBITDA$2.75B$2.81B$2.34B$2.06B$2.47B
EPS (basic)10.0611.027.626.039.30
EPS (diluted)9.8410.737.425.858.90
Weighted avg. shares (diluted)75.89M87.27M93.18M95.83M109.95M
Balance sheet
Cash & equivalents$676.44M$879.83M$464.63M$338.99M$554.96M
Short-term investments$24.30M$51.06M$11.61M$77.69M$22.31M
Receivables$2.41B$2.15B$1.99B$2.13B$1.96B
Inventory$160.63M$134.56M$143.10M$109.12M$107.43M
Current assets$4.06B$3.75B$3.14B$3.16B$3.17B
PP&E, net$2.81B$2.94B$3.07B$3.26B$3.48B
Goodwill$7.55B$7.38B$7.11B$7.08B$7.05B
Intangibles$222.12M$197.43M$203.22M$182.69M$177.69M
Total assets$17.48B$17.29B$16.89B$16.93B$17.12B
Current liabilities$3.14B$2.97B$2.64B$2.62B$2.40B
Short-term debt$109.20M$270.87M$123.30M$231.40M$179.03M
Long-term debt$10.16B$9.18B$8.27B$8.69B$8.73B
Total debt$10.27B$9.45B$8.39B$8.92B$8.91B
Total liabilities$16.32B$15.19B$14.15B$14.70B$14.75B
Shareholders' equity-$651.08M$121.12M$1.06B$712.33M$755.51M
Net debt$9.60B$8.57B$7.93B$8.59B$8.35B
Shares outstanding68.55M80.54M88.82M90.41M97.29M
Cash flow statement
Operating cash flow$1.89B$2.02B$2.06B$1.56B$1.93B
Capital expenditure$575.86M$555.44M$567.99M$603.43M$641.47M
Free cash flow$1.31B$1.47B$1.49B$961.14M$1.29B
Investing cash flow-$654.95M-$771.43M-$771.80M-$630.35M-$784.73M
Financing cash flow-$1.37B-$816.94M-$1.17B-$1.12B-$1.08B
Depreciation & amortization$708.25M$716.40M$736.47M$721.13M$667.75M
Stock-based compensation$139.95M$102.79M$112.38M$95.43M$102.21M
Dividends paid$0$0$0$0$0
Share buybacks$1.31B$1.39B$272.22M$802.23M$1.54B

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.